In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1862 News Items found
A researcher working in an MSK lab
MSK Research Highlights, April 27, 2026

New MSK research shows how pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric sarcoma; develops an AI tool could accelerate identification of disease-causing genetic variants; and builds quantum nanosensors for cancer blood tests.
a lab coat hangs in an MSK lab
Drs. Anna-Katerina Hadjantonakis and Robert Farese Elected to the American Academy of Arts and Sciences

Drs. Anna-Katerina Hadjantonakis and Robert Farese were elected to the 2026 class of the American Academy of Arts and Sciences.
Charles Sawyers presents at AACR 2026
AACR 2026 Research Roundup: The Latest Cancer Science Advances From MSK

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.
colorful microscope image of cancer cells
Catching Cancer’s Earliest Moments: How Mutated Cells Transform Their Local Environment So a Tumor Can Develop

MSK scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit accomplices from healthy surrounding tissue to pave the way for a tumor to develop.
Dr. Eileen O'Reilly seen with patient Leanna Stokes and MSK nurse Tiffany Upshaw
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
MSK physician-scientist Vinod Balachandran.
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
MSK Doctors Andrea Cercek and Michael Foote are seen smiling.
Treating HER2-Amplified Early-Stage Rectal Cancer To Improve Quality of Life

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.
Scott Lowe and Dana Pe'er
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped

An MSK study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystems that supports emerging tumors.
Christopher Lima
Dr. Christopher Lima Elected AAAS Fellow

Sloan Kettering Institute Structural Biology Program Chair Dr. Christopher Lima was elected to the 2025 class of American Association for the Advancement of Science Fellows.
whole fresh turmeric root beside a bowl of turmeric powder
The Truth About Turmeric and Cancer

Can turmeric fight cancer? Learn more from an MSK expert about what the science says.